Skip to main content

Table 5 EPIC questionnaire—bowel

From: Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

 

Baseline (n = 90)

1 month (n = 26)

3–4 months (n = 14)

6–9 months (n = 17)

HRQOL Bowel domain summary

    

Mean

92.76

 − 18.03*

0.86

 − 5.89*

Standard deviation

9.52

   

MID

4.76

   

Domain-specific HRQOL subscales

    

Function

    

Mean

91.92

 − 17.88*

2.98

 − 4.95

Standard deviation

10.95

   

MID

5.47

   

Bother

    

Mean

94.32

 − 18.18*

 − 1.97

 − 4.27

Standard deviation

10.34

   

MID

5.17

   
  1. *Indicates a clinically significant decline in HRQOL based on MID